Fate Therapeutics (FATE) Debt to Equity Ratio: 0.56

Fate Therapeutics, Inc. (FATE)

1.28 -0.06 (-4.48%) USD | NASDAQ | Nov 13, 16:00

1.275 0.00 (0.00%) After-Hours: 19:59

Debt to Equity Ratio Chart

Historical Debt to Equity Ratio Data

View and export this data back to 2013. Start Trial.

Date	Value
September 30, 2026	0.56
June 30, 2026	0.4932
March 31, 2026	0.4273
December 31, 2025	0.3757
September 30, 2025	0.3386
June 30, 2025	0.3112
March 31, 2025	0.2889
December 31, 2024	0.2675
September 30, 2024	0.2732
June 30, 2024	0.2533
March 31, 2024	0.2395
December 31, 2023	0.281
September 30, 2023	0.2606
June 30, 2023	0.2429
March 31, 2023	0.2254
December 31, 2022	0.2259
September 30, 2022	0.2141
June 30, 2022	0.1935
March 31, 2022	0.1792
December 31, 2021	0.1691
September 30, 2021	0.1493
June 30, 2021	0.1469
March 31, 2021	0.1404
December 31, 2020	0.2531
September 30, 2020	0.2014

Date	Value
June 30, 2020	0.1709
March 31, 2020	0.3455
December 31, 2019	0.11
September 30, 2019	0.1538
June 30, 2019	0.3339
March 31, 2019	0.2922
December 31, 2018	0.0928
September 30, 2018	0.0855
June 30, 2018	0.2865
March 31, 2018	0.2281
December 31, 2017	0.1918
September 30, 2017	0.3233
June 30, 2017	0.1209
March 31, 2017	0.1363
December 31, 2016	0.1461
September 30, 2016	0.498
June 30, 2016	0.6286
March 31, 2016	0.5339
December 31, 2015	0.4795
September 30, 2015	0.4251
June 30, 2015	0.3856
March 31, 2015	0.9256
December 31, 2014	0.6926
September 30, 2014	0.2978
June 30, 2014	0.0188

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks